SE8601644L - Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning - Google Patents
Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellningInfo
- Publication number
- SE8601644L SE8601644L SE8601644A SE8601644A SE8601644L SE 8601644 L SE8601644 L SE 8601644L SE 8601644 A SE8601644 A SE 8601644A SE 8601644 A SE8601644 A SE 8601644A SE 8601644 L SE8601644 L SE 8601644L
- Authority
- SE
- Sweden
- Prior art keywords
- human
- antibodies
- region
- antibody preparation
- determinants
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rehabilitation Therapy (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8601644A SE452065B (sv) | 1986-04-11 | 1986-04-11 | Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning |
PCT/SE1987/000142 WO1987006344A1 (en) | 1986-04-11 | 1987-03-19 | Antibody preparation directed against neoantigens in human c3 (complement factor 3) and the use and manufacture thereof |
AU72868/87A AU7286887A (en) | 1986-04-11 | 1987-03-19 | Antibody preparation directed against neoantigens in human c3 (complement factor 3) and the use and manufacture thereof |
EP19870902799 EP0263161A1 (en) | 1986-04-11 | 1987-03-19 | Antibody preparation directed against neoantigens in human c3 (complement factor 3) and the use and manufacture thereof |
JP50252087A JPS63503089A (ja) | 1986-04-11 | 1987-03-19 | ヒトc3中のある抗原決定基に対する抗体調製物及びその使用並びにその生産 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8601644A SE452065B (sv) | 1986-04-11 | 1986-04-11 | Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8601644D0 SE8601644D0 (sv) | 1986-04-11 |
SE8601644L true SE8601644L (sv) | 1987-10-12 |
SE452065B SE452065B (sv) | 1987-11-09 |
Family
ID=20364149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8601644A SE452065B (sv) | 1986-04-11 | 1986-04-11 | Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0263161A1 (sv) |
JP (1) | JPS63503089A (sv) |
AU (1) | AU7286887A (sv) |
SE (1) | SE452065B (sv) |
WO (1) | WO1987006344A1 (sv) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6572856B1 (en) | 1998-09-10 | 2003-06-03 | The University Of Virginia Patent Foundation | Methods for the prevention and treatment of cancer using anti-C3b(i) antibodies |
CA2328356A1 (en) * | 1999-12-22 | 2001-06-22 | Itty Atcravi | Recreational vehicles |
JP2003522159A (ja) * | 2000-02-08 | 2003-07-22 | ザ ユニバーシティ オブ ヴァージニア パテント ファウンデーション | 抗C3b(i)抗体を用いる感染の予防および治療のための方法 |
US20040224423A1 (en) * | 2001-04-30 | 2004-11-11 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 2056 daltons |
US6617308B2 (en) * | 2001-04-30 | 2003-09-09 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons |
US7294688B2 (en) * | 2001-04-30 | 2007-11-13 | Nanogen Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons |
US7049397B2 (en) * | 2001-04-30 | 2006-05-23 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons |
US7314717B2 (en) | 2001-04-30 | 2008-01-01 | Nanogen Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons |
US20020160434A1 (en) * | 2001-04-30 | 2002-10-31 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1777 daltons |
US6602855B2 (en) * | 2001-04-30 | 2003-08-05 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons |
US6998243B2 (en) | 2001-04-30 | 2006-02-14 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons |
US6756476B2 (en) | 2001-04-30 | 2004-06-29 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons |
US6593298B2 (en) | 2001-04-30 | 2003-07-15 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1690 daltons |
US20020160532A1 (en) * | 2001-04-30 | 2002-10-31 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1998 daltons |
US20050255533A1 (en) * | 2004-02-10 | 2005-11-17 | Brendan Bioscience, Llc | Comprehensive food allergy test |
AR069130A1 (es) * | 2007-11-02 | 2009-12-30 | Novartis Ag | Moleculas de enlace de la opsonina principal del complemento (c3b) y metodos para modular el componente de complemento |
US20100291106A1 (en) * | 2009-05-06 | 2010-11-18 | Novartis Ag | Compositions and methods for antibodies targeting complement protein c3b |
EP2553465A4 (en) * | 2010-03-31 | 2013-10-23 | Anamar Ab | METHOD FOR DETECTING INFLAMMATION TISSUE DEGRADATION |
JP5859557B2 (ja) * | 2010-11-02 | 2016-02-10 | カイファ, インコーポレイテッド | 補体活性化についての側方流動イムノアッセイおよび補体関連障害のポイント・オブ・ケア評価のための使用法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4342566A (en) * | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
GB2117514B (en) * | 1982-03-29 | 1985-08-29 | East Anglian Regional Health | Polyvalent antiglobulin reagent |
US4642284A (en) * | 1983-06-13 | 1987-02-10 | Scripps Clinic And Research Foundation | Method and system for detection of complement pathway activation |
-
1986
- 1986-04-11 SE SE8601644A patent/SE452065B/sv not_active IP Right Cessation
-
1987
- 1987-03-19 EP EP19870902799 patent/EP0263161A1/en not_active Withdrawn
- 1987-03-19 JP JP50252087A patent/JPS63503089A/ja active Pending
- 1987-03-19 WO PCT/SE1987/000142 patent/WO1987006344A1/en not_active Application Discontinuation
- 1987-03-19 AU AU72868/87A patent/AU7286887A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JPS63503089A (ja) | 1988-11-10 |
WO1987006344A1 (en) | 1987-10-22 |
SE8601644D0 (sv) | 1986-04-11 |
EP0263161A1 (en) | 1988-04-13 |
AU7286887A (en) | 1987-11-09 |
SE452065B (sv) | 1987-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8601644L (sv) | Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning | |
EP0597829A4 (en) | NEW MONOCLONAL ANTIBODY DRESSES AGAINST A NEW ANTIGEN ASSOCIATED WITH HUMAN TUMORS. | |
FI930580A (fi) | Tri- och tetravalensiska monopecifika antigen bindande proteiner | |
DK0403156T3 (da) | Forbedrede monoklonale antistoffer mod den humane alfa/beta-T-cellereceptor samt fremstilling og anvendelse deraf | |
IE832452L (en) | Lymphocyte growth factor | |
AU612683B2 (en) | Synthetic peptides, antibodies directed against them, and the use thereof | |
ATE151882T1 (de) | Karzinomverwandtes haptoglobin (hpr) | |
NO175639C (no) | Peptid, antistoff oppnådd ved hjelp av peptidet, en fremgangsmåte for immunologisk bestemmelse av intakt prokollagen peptid (type III) og anvendelse av peptidet | |
DE3884646D1 (de) | Humanes Karcinom-assoziertes Antigen und an dieses Antigen bindende Antikörper. | |
ATE124539T1 (de) | Immunogen und seine verwendung zur gewinnung von antikörpern gegen hba1c. | |
ATE230418T1 (de) | Monoklonaler antikörper gegen das humane mx- protein mxa | |
ATE72400T1 (de) | Kreuzreaktive und schuetzende epitope von circumsporozoit-proteinen. | |
NO174153C (no) | Antigen og monoklonalt antistoff for anvendelse in vitro, samt immunologiske reagenser inneholdende disse | |
IT8026986A0 (it) | Antigene di prostata umana purificato e procedimento per preparare anticorpi correlati a tale antigene. | |
DE69026875D1 (de) | Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür | |
DE3785795D1 (de) | Monoklonale anti-menschliche magenkrebs-antikoerper. | |
GB2233091A (en) | Immunoassays using monoclonal antibodies directed against natural binding proteins | |
SE8904007D0 (sv) | Monoklona antikroppar och diagnostiseringsmetod | |
DK329789D0 (da) | Monoklonalt antistof | |
ATE86261T1 (de) | Tumorassoziiertes antigen. | |
DE69111429D1 (de) | Monoklonale antikörper, die einen unterschied zwischen nativproteinen und proteinen mit einer modifizierten sequenz machen. | |
ATE92081T1 (de) | Tumorassoziiertes antigen. | |
DE68926813D1 (de) | Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide | |
KR890009417A (ko) | 모노크로날 항체의 제조방법 및 그것의 이용방법 | |
GR890100333A (en) | Antihuman antigen antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 8601644-1 Effective date: 19911108 Format of ref document f/p: F |